FDA Approved Therapy for SOD1 Associated ALS

episode

Neurology Minute not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

Related

recent transcribed audio

Legal AF 9/26/2026 1h 26m · 27 Sep 2026 · Legal AF by MeidasTouch

Trump Cuts Trip Short as Iran Tensions and Political Pressure Mount 16 min · 27 Sep 2026 · The MeidasTouch Podcast

The Interviews | Ari Emanuel, Tom Morello, Jessica Tarlov, Merritt Wever 1h 19m · 27 Sep 2026 · The Daily Show: Ears Edition

Massachusetts Took Their Daughter After They Refused To Affirm Her Gender 14 min · 27 Sep 2026 · Morning Wire

Always in Blossom | Joel Osteen 30 min · 27 Sep 2026 · Joel Osteen Podcast

NPR News: 09-27-2026 4AM EDT 5 min · 27 Sep 2026 · NPR News Now

Report any issue

Source

Recorded19 May 2023

Publisherneurologyminute.libsyn.com ↗

Handlerec:10217966

Show notes

Dr. Suma Babu discusses a new approved treatment for ALS that is associated with a mutation in the superoxide dismutase 1 (SOD1) gene. Show references: https://www.fda.gov/drugs/news-events-human-drugs/fda-approves-treatment-amyotrophic-lateral-sclerosis-associated-mutation-sod1-gene This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Sign in